Abstract Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin-receptor (IR) signaling and, when over-expressed, induces insulin resistance in vitro and in vivo. Understanding the regulation of ENPP1 expression may, thus, unravel new molecular mechanisms of insulin resistance. Recent data point to a pivotal role of the ENPP1 3'UTR, in modulating ENPP1 mRNA stability and expression. We sought to identify trans-acting proteins binding the ENPP1-3'UTR and to investigate their role on ENPP1 expression and on IR signaling. By RNA electrophoresis mobility shift analysis and tandem mass spectrometry, we demonstrated the binding of heat shock protein 70 (HSP70) to ENPP1-3'UTR. Through this binding, HSP70 stabilizes ENPP1 mRNA and increases ENPP1 transcript and protein levels. This positive modulation of ENPP1 expression is paralleled by a reduced insulin-induced IR and IRS-1 phosphorylation. Taken together these data suggest that HSP70, by affecting ENPP1 expression, may be a novel mediator of altered insulin signaling.
Introduction
Insulin resistance is pathogenic for type 2 diabetes and cardiovascular disease [1] . Unraveling the molecular mechanisms underlying this syndrome is urgently needed.
Ectoenzyme nucleotide pyrophosphate phosphodiesterase 1 (ENPP1) has been proposed as a pathogenic factor for insulin resistance [2] . ENPP1 affects insulin signaling by binding to IR α-subunit and inhibiting receptor β-subunit autophosphorylation [3, 4] . ENPP1 expression is increased in tissues of insulin-resistant individuals [5, 6] . In addition, ENPP1 over-expression causes insulin resistance in rodents. [7, 8] . Finally, several data indicate that gain of function of ENPP1 (as induced by the missense K121Q polymorphism) contribute to insulin resistance and type 2 diabetes [7] [8] [9] . Thus, determining the mechanisms whereby ENPP1 is over-expressed may help develop strategies to counteract and possible reverse some forms of insulin resistance. Recent data point to a pivotal role of the ENPP1-3'UTR [10, 11] , suggesting the existence of transacting proteins that affect ENPP1 mRNA stability. Our aim was to identify these proteins and investigate their role in the modulation of ENPP1 expression and insulin signaling.
Material and methods
Preparation of RNA probes as well as cell culture and solubilization are described in the online appendix methods
RNA electrophoresis mobility shift analysis (REMSA)
Fifty microgram of HEK293 lysates were incubated with the 32 P-labeled-RNA probe for 20 min at room temperature (RT) [12] . Following incubation with heparin (5 mg/ml), gel electrophoresis was carried out at RT on 5% nondenaturing PAGE and visualized by autoradiography on Typhoon 8600 (Amersham). For supershift analysis, HEK293 lysates were incubated with 32 P-labeled-RNA before adding either heat shock protein 70 (HSP70) specific antibody (SPA-812, Stressgen) or total IgG (Santa Cruz Biotechnology) for 30 min at RT.
Isolation of ENPP1-RNA binding protein REMSA was carried as described above. Four gels of 15 lanes each were loaded. High molecular weight complexes, located by a 1-h exposure to X-ray film at −80°C, were excised and eluted from the gel [12] . Proteins were pooled, concentrated by acetone precipitation and resolved on 10% SDS-PAGE. The only band present in the gel with an apparent molecular weight of 70 kD was excised, and washed twice with 50% HPLC-grade acetonitrile before subsequent analysis. After proteolytic digestion, peptide composition analysis was performed at the Harvard Microchemistry Facility, Harvard University, (Cambridge, MA USA; http://www.mcb.harvard.edu/microchem/) by microcapillary reverse-phase HPLC nano-electrospray tandem mass spectrometry (μLC/MS/MS) on a Finnigan LCQ DECA XP Plus quadrupole ion trap mass spectrometer.
RNA extraction, cDNA synthesis, and gene expression analysis Total RNA was isolated from cells using RNAEasy Quick kit (Qiagen). cDNA was generated by reverse transcription with M-MLV Reverse Transcriptase (Promega) and used as template in the subsequent analyses. Gene Expression Assay on Demand Kit Reagents (Applera) were used to quantify relative gene expression levels of ENPP1 and GAPDH on ABI-PRISM 7500 (Applera). Expression levels of ENPP1 were normalized against GAPDH using the comparative C t method, and expressed as percentage of control.
siRNA, cell transfections
Cells were seeded in six-well plates and grown in DMEM/F12 complete medium for 48 h. To down-regulate HSP70 expression, 150 nmol/L of siRNA targeted against HSP70 mRNA (Ambion ID number: 202680 was the only oligonucleotide used in our experiments) were either cotransfected or not with ENPP1 cDNAs by using TransMessanger Transfection Reagent (Qiagen) according to the manufacturer's instructions.
Cell lines stably over-expressing IR cDNA (HEK293-IR) were generated by co-transfection of the prk5-IR (provided by Dr. Axel Ulrich, Martinsried Germany) and prk-5neo followed by geneticin selection IR expression was evaluated by western blot (WB) as described below. HEK293-IR were transiently transfected with prk7-ENPP1 and/or with pCMVSport6-HSP70 plasmid (ATCC) by using FuGENE6 (Roche).
Western blot analysis
Cell lysates were separated by SDS-PAGE and transferred to nitrocellulose membrane (Amersham Pharmacia Biotech). Blots were probed with following antibodies: anti-HSP70 (SPA-812, Stressgen), anti-IRβ-subunit (C19, Santa Cruz Biotechnology), anti-PY (PY99 HRP, Santa Cruz Biotechnology), anti-ENPP1 (N-20, Santa Cruz Biotechnology) and anti-IRS-1 (A-19, Santa Cruz Biotechnology). Alternatively, cell lysates were immunoprecipitated with anti-PY antibody (4G10, Millipore) and analyzed by WB using IRβ-subunit or IRS-1 antibodies. Immunocomplexes were detected with the ECL Western Blotting System (Amersham Pharmacia Biotech).
ENPP1 mRNA stability ENPP1 mRNA stability was evaluated by adding Actinomycin D (5 μg/ml) 60 h after HSP70 silencing. RNA extraction was performed at different times as described above, and ENPP1 expressions determined as described.
Insulin stimulation
Insulin (10 nmol/L for 5' at 37°C) was added to cells and total cell lysates were either immunoprecipitated or not before SDS-PAGE. IRβ-subunit and IRS-1 phosphorylation were evaluated by WB as described.
Results
Identification and characterization of an ENPP1-3'UTR protein complex REMSA was performed by incubating HEK293 cell extracts with a 395-bp probe corresponding to the ENPP1-3'UTR showing a high degree of conservation between human and mouse genomes (Supplementary Figure 1) . RNA-protein complex was indicated by bandshift observed in the presence of the probe (Supplementary Figure 2, lanes 1-2) . SDS-PAGE of the eluted shifted-band revealed a single protein in the RNA-protein complex. This was identified by tandem mass spectrometry as the 70 kDa HSP70 encoded by the HSPA1B isoform (Supplementary Figure 3) . Addition of increasing amount of HSP70 antibody to the RNA-cell extract mixture induced a gradual loss of the high molecular complex (Supplementary Figure 2, lanes 3-10) , confirming the specific interaction between HSP70 and ENPP1-3'UTR.
Effect of HSP70 on ENPP1 expression
We evaluated the effect of HSP70 down-regulation on ENPP1 mRNA stability and expression by transfecting HEK293 cells with HSP70-siRNA. Exposure to the siRNA decreased HSP70 by approximately 80% (Fig. 1a) . After transcription inhibition by Actinomycin D, a progressive reduction in ENPP1 mRNA levels was observed (Fig. 1b) ; . HSP70 expression was evaluated by western blot by using HSP70 SPA-812 specific antibody. b ENPP1 mRNA stability. ENPP1 mRNA content was determined by real time PCR (after transcription inhibition by 5 μg/ml Actinomycin-D) in HEK293 cells either treated (square) or not (circle) with HSP70 siRNA. A significantly greater reduction of mRNA content over time (p=0.04, by two-way ANOVA) was observed in HSP70 downregulated cells as compared to control cells. Expression levels of ENPP1 were normalized against GAPDH using the comparative C t method, expressed as percentage of untreated cells at time 0 (Endogenous levels of ENPP1 expression were detectable with Ct values being 26.4±1.3, as compared to those of GAPDH being 15.7± 1.9). Data are mean±SD (n=4 experiments in each group). c ENPP1 levels in transfected HEK293 cells. ENPP1 mRNA content was determined by real-time PCR in HEK293 cells transfected with ENPP1 cDNA and treated (black bar) or not (white bar) with HSP70 siRNA. The grey bar represents ENPP1 levels in untransfected cells. HSP70 down-regulation caused 80% significant reduction (p= 0.016 by paired sample t-test) of ENPP1 transcript. Expression levels of ENPP1 were normalized against GAPDH using the comparative C t method, expressed as percentage of untreated cells (white bar). Data are means±SD (n=3 experiments in each group). d ENPP1 protein content. HEK293 cells transfected with either ENPP1 cDNA or with ENPP1 cDNA lacking 3'UTR (ENPP1 Δ,3'UTR lanes 3-4) were treated (+) or not (−) with HSP70 siRNA. Total cell lysates were then used to measure HSP70, (by using HSP70 SPA-812 specific antibody) and ENPP1 (by using ENPP1 N-20 specific antibody) protein content. HSP70 down-regulation had no effect on ENPP1 protein content when ENPP1 Δ3'UTR cDNA was used the reduction, however, was significantly greater in HSP70 down-regulated than control cells (p<0.01; Fig. 1b) . We also evaluated the effect of HSP70-siRNA on steady state levels of ENPP1 mRNA and protein in cells transfected with ENPP1 cDNA. Both mRNA (Fig. 1c) and protein (Fig. 1d, lanes 1-2) contents were lower following HSP70 down-regulation. This was not observed when ENPP1 cDNA lacked the 3'UTR (Fig. 1d, lanes 3-4) . We then evaluated the effect of HSP70 over-expression (i.e. by HSP70 cDNA transfection) on ENPP1 protein content in cells co-transfected with ENPP1 cDNA. ENPP1 protein levels were approximately 30% higher in co-transfected cells as compared to HEK293 transfected with ENPP1 cDNA alone (Fig. 2) , thus confirming that HSP70 levels affects ENPP1 expression.
Effect of HSP70 down-regulation on insulin signaling
When HSP70 expression was down-regulated in HEK293-IR cells, insulin-stimulated IR autophosphorylation was 2.5-to threefold higher than in control cells (Fig. 3a: lanes 2 vs. lane 1; Fig. 3b : second bar vs. first bar). In contrast, in cells transfected with ENPP1 cDNA, insulin-induced IR autophosphorylation was markedly inhibited (Fig. 3a, lanes 3 vs. lane 1; Fig. 3b : third bar vs. first bar). This inhibition was partially abolished by HSP70 down-regulation (Fig. 3a lane  4 vs. lane 3; Fig. 3b : fourth bar vs. third bar), a rescue which was paralleled by a reduction of ENPP1 over-expression (Fig. 3a lanes 3-4) . Neither the partial rescue of IR autophosphorylation (Fig. 3a lanes 5-6 and Fig. 3b sixth bar vs. fifth bar) nor the reduced ENPP1 expression (Fig. 3a  lanes 5-6) was observed when cells were transfected with ENPP1 cDNA lacking the 3'UTR. In human liver HepG2 cells, HSP70 down-regulation increased insulin-induced IR and IRS-1 phosphorylation (Fig. 3c lane 3 vs. lane 2) . As compared to control cells, insulin-induced IRβ-subunit autophosphorylation and IRS-1 phosphorylation were higher in cells treated with HSP70 siRNA (153% and 274% increase, respectively, mean of two different experiments). 
Discussion
The two major messages of our study are as follows 1) by binding ENPP1-3'UTR, HSP70 stabilizes ENPP1 mRNA and eventually increases ENPP1 transcript and protein levels; 2) through the modulation of ENPP1 expression, HSP70 affects insulin-induced IR and IRS-1 phosphorylation, thus becoming a new potential modulator of insulin resistance. Similar data were observed in two different cell lines, thus suggesting this phenomenon occurs in several insulin target tissues. To the best of our knowledge, this is the first report elucidating a molecular mechanism which modulates ENPP1 expression and, consequently, affects IR signaling.
Most of the molecular mechanisms of insulin resistance so far described are located at the downstream 'postreceptor level'. However, recent functional, metabolic [5, 13, 14] and genetic studies [9] [10] [11] [15] [16] [17] [18] [19] [20] [21] [22] [23] have suggested that an additional mechanism of insulin resistance resides at the 'receptor level' and is mediated by ENPP1 [2] . In this context, we propose HSP70 as a new potential contributor to insulin resistance through up-regulation of ENPP1 expression and subsequent inhibition of IR-autophosphorylation. Of note, HSP70 is known to bind and modulate other 3'UTRs of yeast and human mRNAs [24, 25] .Very recently an opposite role of HSP70 on insulin signaling has been reported in transgenic animal models [26] . The proposed mechanism is mediated by HSP70-inhibition of JNK activation, a negative modulator of IRS-1 signaling. These discrepancies are difficult to reconcile and might be due to relevant differences intrinsic to the study models utilized (i.e. in vivo obese rodents vs. in vitro human cells) or variable tissue-specific expression. Further studies are clearly needed to acquire deeper insights on the potential role of HSP70 in both cellular and human insulin resistance.
